• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory)

  • For research use only

Cat No.

ABC-TC3947

Product Type

Immune Cells

Cell Type

Mononuclear Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Multiple Myeloma

Storage

Liquid Nitrogen

Leverage Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory) for drug resistance analysis, immune profiling, and tumor progression.

Product Image

Description

Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory) are primary cells isolated from the bone marrow of donors with relapsed or refractory multiple myeloma. These cells are non-passaged and exhibit a mixed morphology with atypical plasma cells and mononuclear subsets in suspension. Functionally, these human bone marrow cells display characteristic in vitro profiles associated with multidrug resistance, anti-apoptotic signaling, and microenvironment-related cell survival. The cells express CD38. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.​

Product Code

Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory), MM BM-MNCs, Relapsed Multiple Myeloma BM MNCs, Refractory Myeloma Bone Marrow Cells

Species

Human

Cat.No

ABC-TC3947

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Multiple Myeloma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory) serve as an in vitro model to study disease-associated drug resistance profiles and underlying molecular mechanisms. For instance, analyzing their survival under chemotherapy, drug efflux pump expression, and altered signaling pathways helps explore molecular drivers of treatment resistance, supporting discovery research and target identification for myeloma drug resistance.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Multiple Myeloma Bone Marrow Mononuclear Cells (Relapsed/Refractory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button